Cargando…
Ablative strategies for recurrent hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the fifth leading cause of cancer death worldwide and the third leading cause of all diseases worldwide. Liver transplantation, surgical resection and ablation are the three main curative treatments for HCC. Liver transpla...
Autores principales: | Wang, Lin, Liu, Bao-Xian, Long, Hai-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190693/ https://www.ncbi.nlm.nih.gov/pubmed/37206650 http://dx.doi.org/10.4254/wjh.v15.i4.515 |
Ejemplares similares
-
Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
por: Cong, Rong, et al.
Publicado: (2023) -
Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023) -
Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
por: Wang, Di, et al.
Publicado: (2023) -
Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
por: Bo, Xiao-Wan, et al.
Publicado: (2021) -
Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)